Fondazione IRCCS - Istituto Nazionale dei Tumori - Milano

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients	Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm	Active, not recruiting	Phase 3	2026-10-08		NCT05899608
IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)	Advanced Melanoma	Recruiting	Phase 3	2026-02-25		NCT06112314

Clinical trials